TO MANDATE THE USE OF BIOSIMILAR MEDICINES UNDER HEALTH BENEFIT PLANS; TO REQUIRE A HEALTHCARE PROVIDER TO PRESCRIBE BIOSIMILAR MEDICINES; AND TO IMPROVE ACCESS TO BIOSIMILAR MEDICINES.

Latest action: Sine Die adjournment

Voted 5/5/2025

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

5/5/2025Sine Die adjournment
4/1/2025Recommended for study in the Interim Committee on INSURANCE & COMMERCE - SENATE
4/1/2025Withdrawn from Committee and placed on calendar.
3/10/2025Re-referred to INSURANCE & COMMERCE - SENATE
3/10/2025REPORTED CORRECTLY ENGROSSED
3/10/2025Amendment # 2 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
3/10/2025Withdrawn from Committee and placed on 2nd reading for purpose of amendment # 2
2/5/2025Re-referred to INSURANCE & COMMERCE - SENATE
2/5/2025REPORTED CORRECTLY ENGROSSED
2/5/2025Amendment # 1 read the first time, rules suspended, read the second time and adopted, ordered engrossed.